Skip to content

Insider · CIK 0001688222

CRONIN JANE M.

officerdirector

Files at SHW (SHERWIN WILLIAMS CO), TDG (TransDigm Group INC). First filing Nov 27, 2024, latest Nov 27, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $2.1M sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
38Weaksell 2SHW
SHERWIN WILLIAMS CO
$2.1M5,161-23%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 25, 2024SHW
SHERWIN WILLIAMS CO
MOption exercise
Common Stock
+1,461$140.10$205k18,277Nov 27, 2024
Nov 25, 2024SHW
SHERWIN WILLIAMS CO
MOption exercise
Common Stock
+3,700$136.85$506k21,977Nov 27, 2024
Nov 25, 2024SHW
SHERWIN WILLIAMS CO
SOpen-market sale
Common Stock
-5,161$398.06$2.1M16,816Nov 27, 2024
Nov 25, 2024SHW
SHERWIN WILLIAMS CO
MOption exercise
Common Stock
+338$295.83$100k17,154Nov 27, 2024
Nov 25, 2024SHW
SHERWIN WILLIAMS CO
FTax withholding
Common Stock
-251$397.93$100k16,903Nov 27, 2024
Nov 25, 2024SHW
SHERWIN WILLIAMS CO
GGift
Common Stock
-543$0.00$016,360Nov 27, 2024
Nov 25, 2024SHW
SHERWIN WILLIAMS CO
MOption exercise
Employee Stock Option (Right to Buy)derivative
-1,461$0.00$00Nov 27, 2024
Nov 25, 2024SHW
SHERWIN WILLIAMS CO
MOption exercise
Employee Stock Option (Right to Buy)derivative
-3,700$0.00$00Nov 27, 2024
Nov 25, 2024SHW
SHERWIN WILLIAMS CO
MOption exercise
Employee Stock Option (Right to Buy)derivative
-338$0.00$02,562Nov 27, 2024
Oct 31, 2024TDG
TransDigm Group INC
AGrant or award
Stock Optionderivative
+450$0.00$0450Nov 20, 2024
Oct 15, 2024SHW
SHERWIN WILLIAMS CO
AGrant or award
Employee Stock Option (Right to Buy)derivative
+2,100$0.00$02,100Oct 17, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.